Vicore Pharma Holding AB (publ) (STO:VICO)
9.84
-0.40 (-3.91%)
Nov 20, 2026, 5:29 PM CET
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 594.00K SEK in the quarter ending September 30, 2026, a decrease of -21.84%. This brings the company's total for the last twelve months to 3.83M, down -54.97% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%. That makes Vicore Pharma Holding AB the 44,884th largest company in the world by revenue and 717th in Sweden.
Revenue (ttm)
3.83M
Revenue Growth
-54.97%
P/S Ratio
723.98
Revenue / Employee
76.56K
Employees
50
Market Cap
2.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.82M | -105.53M | -96.51% |
| Dec 31, 2024 | 109.35M | - | - |
| Dec 31, 2023 | 0 | - | - |
| Dec 31, 2022 | 0 | - | - |
| Dec 31, 2021 | 0 | - | - |
| Dec 31, 2020 | 0 | - | - |
| Dec 31, 2019 | 0 | - | - |
| Dec 31, 2018 | 508.00K | -424.00K | -45.49% |
| Dec 31, 2017 | 932.00K | 80.00K | 9.39% |
| Dec 31, 2016 | 852.00K | 12.00K | 1.43% |
| Dec 31, 2015 | 840.00K | -11.00K | -1.29% |
| Dec 31, 2014 | 851.00K | 131.00K | 18.19% |
| Dec 31, 2013 | 720.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Saniona AB | 424.56M |
| Hansa Biopharma AB | 301.64M |
| Genovis AB (publ.) | 145.23M |
| Oncopeptides AB | 103.50M |
| Egetis Therapeutics AB | 70.00M |
| Medivir AB | 8.51M |
| Xspray Pharma AB | 7.19M |
| Flerie AB | 2.60M |
Vicore Pharma Holding AB News
- 3 days ago - Vicore Pharma Holding AB Transcript: Jefferies Global Healthcare Conference - Transcripts
- 9 days ago - Vicore Pharma Holding AB Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 12 days ago - Vicore Pharma Holding AB Slides: Corporate presentation - Filings
- 13 days ago - Vicore Pharma Holding AB Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 17 days ago - Vicore Pharma Holding AB Quarterly report: Q3 2026 - Filings
- 17 days ago - Vicore Pharma initiated with a Buy at Chardan - TheFly
- 27 days ago - Vicore Pharma Holding AB Slides: Company presentation - Filings
- 4 weeks ago - Vicore Pharma Holding AB Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts